352 related articles for article (PubMed ID: 28182987)
1. Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.
Rogolino D; Cavazzoni A; Gatti A; Tegoni M; Pelosi G; Verdolino V; Fumarola C; Cretella D; Petronini PG; Carcelli M
Eur J Med Chem; 2017 Mar; 128():140-153. PubMed ID: 28182987
[TBL] [Abstract][Full Text] [Related]
2. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.
Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR
Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305
[TBL] [Abstract][Full Text] [Related]
4. Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.
Deng J; Yu P; Zhang Z; Wang J; Cai J; Wu N; Sun H; Liang H; Yang F
Eur J Med Chem; 2018 Oct; 158():442-452. PubMed ID: 30241011
[TBL] [Abstract][Full Text] [Related]
5. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
6. Copper(II) complexes of hybrid hydroxyquinoline-thiosemicarbazone ligands: GSK3β inhibition due to intracellular delivery of copper.
Hickey JL; Crouch PJ; Mey S; Caragounis A; White JM; White AR; Donnelly PS
Dalton Trans; 2011 Feb; 40(6):1338-47. PubMed ID: 21173986
[TBL] [Abstract][Full Text] [Related]
7. Anticancer potency of copper(II) complexes of thiosemicarbazones.
Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, X-ray structure and in vitro cytotoxicity studies of Cu(I/II) complexes of thiosemicarbazone: special emphasis on their interactions with DNA.
Saswati ; Chakraborty A; Dash SP; Panda AK; Acharyya R; Biswas A; Mukhopadhyay S; Bhutia SK; Crochet A; Patil YP; Nethaji M; Dinda R
Dalton Trans; 2015 Apr; 44(13):6140-57. PubMed ID: 25736331
[TBL] [Abstract][Full Text] [Related]
9. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
[TBL] [Abstract][Full Text] [Related]
10. Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis.
Qi J; Yao Q; Tian L; Wang Y
Eur J Med Chem; 2018 Oct; 158():853-862. PubMed ID: 30248656
[TBL] [Abstract][Full Text] [Related]
11. Halo-substituted thiosemicarbazones and their copper(II), nickel(II) complexes: detailed spectroscopic characterization and study of antitumour activity against HepG2 human hepatoblastoma cells.
Jagadeesh M; Kalangi SK; Sivarama Krishna L; Reddy AV
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():552-6. PubMed ID: 24084484
[TBL] [Abstract][Full Text] [Related]
12. Solution equilibrium, structural and cytotoxicity studies on Ru(η
Dömötör O; Kiss MA; Gál GT; May NV; Spengler G; Nové M; Gašparović AČ; Frank É; Enyedy ÉA
J Inorg Biochem; 2020 Jan; 202():110883. PubMed ID: 31689626
[TBL] [Abstract][Full Text] [Related]
13. Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism.
Zhang Z; Gou Y; Wang J; Yang K; Qi J; Zhou Z; Liang S; Liang H; Yang F
Eur J Med Chem; 2016 Oct; 121():399-409. PubMed ID: 27309677
[TBL] [Abstract][Full Text] [Related]
14. Thiosemicarbazone(s)-anchored water soluble mono- and bimetallic Cu(ii) complexes: enzyme-like activities, biomolecular interactions, anticancer property and real-time live cytotoxicity.
Balakrishnan N; Haribabu J; Dhanabalan AK; Swaminathan S; Sun S; Dibwe DF; Bhuvanesh N; Awale S; Karvembu R
Dalton Trans; 2020 Jul; 49(27):9411-9424. PubMed ID: 32589180
[TBL] [Abstract][Full Text] [Related]
15. L- and D-proline thiosemicarbazone conjugates: coordination behavior in solution and the effect of copper(II) coordination on their antiproliferative activity.
Milunovic MN; Enyedy É; Nagy NV; Kiss T; Trondl R; Jakupec MA; Keppler BK; Krachler R; Novitchi G; Arion VB
Inorg Chem; 2012 Sep; 51(17):9309-21. PubMed ID: 22889304
[TBL] [Abstract][Full Text] [Related]
16. Effects of polar substituents on the biological activity of thiosemicarbazone metal complexes.
Bisceglie F; Tavone M; Mussi F; Azzoni S; Montalbano S; Franzoni S; Tarasconi P; Buschini A; Pelosi G
J Inorg Biochem; 2018 Feb; 179():60-70. PubMed ID: 29175629
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial, antifungal and in vitro antileukaemia activity of metal complexes with thiosemicarbazones.
Pahontu E; Julea F; Rosu T; Purcarea V; Chumakov Y; Petrenco P; Gulea A
J Cell Mol Med; 2015 Apr; 19(4):865-78. PubMed ID: 25708540
[TBL] [Abstract][Full Text] [Related]
18. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of expanded coordination bis-thiosemicarbazones and copper complexes thereof.
Akladios FN; Andrew SD; Parkinson CJ
J Biol Inorg Chem; 2016 Dec; 21(8):931-944. PubMed ID: 27645502
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl-3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde.
Leovac VM; Bogdanović GA; Jovanović LS; Joksović L; Marković V; Joksović MD; Denčić SM; Isaković A; Marković I; Heinemann FW; Trifunović S; Đalović I
J Inorg Biochem; 2011 Nov; 105(11):1413-21. PubMed ID: 21955843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
